NBP Stock Analysis: Buy, Sell, or Hold?
$1.60
-0.03 (-1.84%)
▼
5d:
+0.63%
30d:
-19.19%
90d:
+6.67%
HOLD
LOW Confidence
Analysis Updated: Sep 18, 2026 12:00 AM ET
Earnings: Sep 23, 2026
1d
Get Alerted When NBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NBP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NBP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NBP is currently trading at $1.60, which is considered oversold relative to its 30-day fair value range of $1.67 to $1.93.
Technical Outlook: Technically, NBP is in a downtrend. The price is currently testing key support at $1.56. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NBP scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.00 (+462.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NBP is in a downtrend. The price is currently testing key support at $1.56. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NBP scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.00 (+462.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.67 -
$1.93
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 462.5% below Wall St target ($9.00)
- CAUTION: Bottoming setup, but lagging the sector by 18% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.67 -
$1.93
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.57
Resistance Level
$1.83
Current Trend
Downtrend
Technical data as of
Sep 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.54
Wall Street Target
$9.00
(+462.5%)
Share & Embed Analysis
Last updated: September 20, 2026 8:59 PM ET
Data refreshes hourly during market hours. Next update: 9:59 PM
Data refreshes hourly during market hours. Next update: 9:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 49 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$849 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 31 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$291 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 54 HOLD |